A recent study showed that inhibition of the critical transcription factor ZEB2 in ABCs could alleviate lupus pathogenesis, suggesting the therapeutic potential of targeting ABCs in autoimmune disease [30]. The gene discussed is ZEB2; the disease is systemic lupus erythematosus.